↓ Skip to main content

A case of molecularly profiled extraneural medulloblastoma metastases in a child

Overview of attention for article published in BMC Medical Genomics, January 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A case of molecularly profiled extraneural medulloblastoma metastases in a child
Published in
BMC Medical Genomics, January 2018
DOI 10.1186/s12881-018-0526-8
Pubmed ID
Authors

Nahla Ali Mobark, Musa Al-Harbi, Othman Mosleh, Sandro Santagata, Matija Snuderl, Malak Abedalthagafi

Abstract

Extraneural metastases are relatively rare manifestations of medulloblastoma. We present the case of a young boy with group three MYCN-amplified medulloblastoma. He received multimodal chemotherapy consisting of gross total resection followed by postoperative craniospinal radiation and adjuvant chemotherapy. The patient developed extraneural metastases 4 months after the end of therapy. Literature review identifies the poor prognosis of MYCN-amplified medulloblastomas as well as extraneural metastases; we review the current limitations and future directions of medulloblastoma treatment options. To the best of our knowledge, this is the first molecularly characterized report of extraneural metastases of medulloblastoma in a child.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 9%
Researcher 2 9%
Student > Bachelor 2 9%
Professor > Associate Professor 2 9%
Lecturer 1 5%
Other 5 23%
Unknown 8 36%
Readers by discipline Count As %
Medicine and Dentistry 9 41%
Chemical Engineering 1 5%
Physics and Astronomy 1 5%
Unspecified 1 5%
Unknown 10 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2018.
All research outputs
#14,283,318
of 25,382,440 outputs
Outputs from BMC Medical Genomics
#854
of 2,444 outputs
Outputs of similar age
#216,308
of 451,258 outputs
Outputs of similar age from BMC Medical Genomics
#17
of 55 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,444 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,258 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.